Abstract
Curcumin ((1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl) hepta-1,6-diene-3,5-dione) is a naturally occurring polyphenol. We have investigated effects of curcumin on human erythrocytes membrane naïve and subjected to in vitro oxidative stress by incubating with tert-butylhydroperoxide (t-BHP). Human erythrocytes have been chosen for the study model due to their being the primary target site for the oxidative stress generated by extracellular as well as intracellular metabolic pathway and substances. Acetylcholinesterase (AChE) in the erythrocytes membrane shows many properties similar to those of brain tissues AChE activity may be considered as central cholinergic status. Results show that curcumin (10-5 M to 10-8 M) significantly (p<0.001) protects AChE activity in erythrocyte during oxidative stress. AChE activity in naïve membrane was found to be maximum at 10-6 M of curcumin. Curcumin at 10-6 M caused decrease in Km of the enzyme Our results signify the potential protective effect of curcumin on the cholinergic system under conditions of oxidative stress.
Keywords: Acetylcholine esterase, Antioxidants, Curcumin, Malondialdehyde, Oxidative stress, Membrane fluidity.
Letters in Drug Design & Discovery
Title:Curcumin Activates Erythrocyte Membrane Acetylcholinesterase
Volume: 10 Issue: 6
Author(s): Prabhakar Singh and Syed Ibrahim Rizvi
Affiliation:
Keywords: Acetylcholine esterase, Antioxidants, Curcumin, Malondialdehyde, Oxidative stress, Membrane fluidity.
Abstract: Curcumin ((1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl) hepta-1,6-diene-3,5-dione) is a naturally occurring polyphenol. We have investigated effects of curcumin on human erythrocytes membrane naïve and subjected to in vitro oxidative stress by incubating with tert-butylhydroperoxide (t-BHP). Human erythrocytes have been chosen for the study model due to their being the primary target site for the oxidative stress generated by extracellular as well as intracellular metabolic pathway and substances. Acetylcholinesterase (AChE) in the erythrocytes membrane shows many properties similar to those of brain tissues AChE activity may be considered as central cholinergic status. Results show that curcumin (10-5 M to 10-8 M) significantly (p<0.001) protects AChE activity in erythrocyte during oxidative stress. AChE activity in naïve membrane was found to be maximum at 10-6 M of curcumin. Curcumin at 10-6 M caused decrease in Km of the enzyme Our results signify the potential protective effect of curcumin on the cholinergic system under conditions of oxidative stress.
Export Options
About this article
Cite this article as:
Singh Prabhakar and Rizvi Syed Ibrahim, Curcumin Activates Erythrocyte Membrane Acetylcholinesterase, Letters in Drug Design & Discovery 2013; 10 (6) . https://dx.doi.org/10.2174/1570180811310060012
DOI https://dx.doi.org/10.2174/1570180811310060012 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Transgenic Mouse Models of Parkinsons Disease and Huntingtons Disease
CNS & Neurological Disorders - Drug Targets AMPA Receptor Antagonists with Additional Mechanisms of Action: New Opportunities for Neuroprotective Drugs?
Current Pharmaceutical Design Brain Excitatory/Inhibitory Circuits Cross-Talking with Chromogranin A During Hypertensive and Hibernating States
Current Medicinal Chemistry Current Developments of Coumarin Compounds in Medicinal Chemistry
Current Pharmaceutical Design Mathematical Modelling and Feature Extraction for Probing Crucial Changes Associated with Alzheimers Disease
Current Medical Imaging Immunotherapy Strategies for Spinal Cord Injury
Current Pharmaceutical Biotechnology Targeted Blockade of TARP-γ8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611)
CNS & Neurological Disorders - Drug Targets Current & Future Therapies of Erectile Dysfunction in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Assessing Structure, Function and Druggability of Major Inhibitory Neurotransmitter γ-Aminobutyrate Symporter Subtypes
Current Medicinal Chemistry Recent Software Developments and Applications in Functional Imaging
Current Pharmaceutical Biotechnology Neonatal Diabetes: Applying Molecular Biology to Patient Care
Current Pediatric Reviews Simultaneous Determination of Lamotrigine, Topiramate, Oxcarbazepine, and 10,11-dihydro-10-hydroxycarbazepine in Human Blood Plasma by UHPLC-MS/MS
Current Analytical Chemistry Prevalence of Tooth Wear in Primary Dentition in School Children of Abu Dhabi, UAE
Applied Clinical Research, Clinical Trials and Regulatory Affairs Using Literature-based Discovery to Identify Novel Therapeutic Approaches
Cardiovascular & Hematological Agents in Medicinal Chemistry Gamma-Decanolactone Improves Biochemical Parameters Associated with Pilocarpine-Induced Seizures in Male Mice
Current Molecular Pharmacology Pharmacoproteomics Applications for Drug Target Discovery in CNS Disorders
Current Pharmacogenomics and Personalized Medicine Cognitive Identity in Schizophrenia: Vision, Space, and Body Perception from Prodrome to Syndrome
Current Psychiatry Reviews Nitric Oxide and Teratogenesis: An Update
Current Pharmaceutical Design Desensitization of 5-HT-1A Somatodentritic Receptors in Tryptophan Treated and Co-treated Rats Induced by Methylphenidate
Current Clinical Pharmacology GABA and Neuroactive Steroid Interactions in Glia: New Roles for Old Players?
Current Neuropharmacology